# Humacyte, Inc.: Form 8-K, filed Jun 11, 2026

- Company: [Humacyte, Inc.](/companies/huma.md) (CIK 1818382)
- Form: 8-K
- Filed: 2026-06-11
- Accepted by EDGAR: Jun 11, 2026, 20:43 ET
- Period: 2026-06-10
- Accession: 0001104659-26-072980
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1818382/000110465926072980/tm2617224d2_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1818382/000110465926072980/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1818382/000110465926072980/tm2617224d2_8k.htm

Filed Jun 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-072980. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.